105 related articles for article (PubMed ID: 29427610)
1. 2,4‑Di‑tert‑butylphenol, a potential HDAC6 inhibitor, induces senescence and mitotic catastrophe in human gastric adenocarcinoma AGS cells.
Song YW; Lim Y; Cho SK
Biochim Biophys Acta Mol Cell Res; 2018 May; 1865(5):675-683. PubMed ID: 29427610
[TBL] [Abstract][Full Text] [Related]
2. Carboxylic acid derivatives display potential selectivity for human histone deacetylase 6: Structure-based virtual screening, molecular docking and dynamics simulation studies.
Uba AI; Yelekçi K
Comput Biol Chem; 2018 Aug; 75():131-142. PubMed ID: 29859380
[TBL] [Abstract][Full Text] [Related]
3. A highly HDAC6-selective inhibitor acts as a fluorescent probe.
Ho YH; Wang KJ; Hung PY; Cheng YS; Liu JR; Fung ST; Liang PH; Chern JW; Yu CW
Org Biomol Chem; 2018 Oct; 16(42):7820-7832. PubMed ID: 30168823
[TBL] [Abstract][Full Text] [Related]
4. Developmental Testicular Expression, Cloning, and Characterization of Rat HDAC6 In Silico.
Verma P; Shetty O; Parab S; Menezes K; Parte P
Biomed Res Int; 2017; 2017():5170680. PubMed ID: 29201907
[TBL] [Abstract][Full Text] [Related]
5. Design and biological evaluation of tetrahydro-β-carboline derivatives as highly potent histone deacetylase 6 (HDAC6) inhibitors.
Leonhardt M; Sellmer A; Krämer OH; Dove S; Elz S; Kraus B; Beyer M; Mahboobi S
Eur J Med Chem; 2018 May; 152():329-357. PubMed ID: 29738953
[TBL] [Abstract][Full Text] [Related]
6. The synergistic combination of the farnesyl transferase inhibitor lonafarnib and paclitaxel enhances tubulin acetylation and requires a functional tubulin deacetylase.
Marcus AI; Zhou J; O'Brate A; Hamel E; Wong J; Nivens M; El-Naggar A; Yao TP; Khuri FR; Giannakakou P
Cancer Res; 2005 May; 65(9):3883-93. PubMed ID: 15867388
[TBL] [Abstract][Full Text] [Related]
7. Pyridylalanine-containing hydroxamic acids as selective HDAC6 inhibitors.
Schäfer S; Saunders L; Schlimme S; Valkov V; Wagner JM; Kratz F; Sippl W; Verdin E; Jung M
ChemMedChem; 2009 Feb; 4(2):283-90. PubMed ID: 19090524
[TBL] [Abstract][Full Text] [Related]
8. Development of Thiazolidinedione-Based HDAC6 Inhibitors to Overcome Methamphetamine Addiction.
Sharma C; Oh YJ; Park B; Lee S; Jeong CH; Lee S; Seo JH; Seo YH
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835389
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of HDAC6 activity through interaction with RanBPM and its associated CTLH complex.
Salemi LM; Maitland MER; Yefet ER; Schild-Poulter C
BMC Cancer; 2017 Jul; 17(1):460. PubMed ID: 28668087
[TBL] [Abstract][Full Text] [Related]
10. A novel HDAC6 inhibitor exerts an anti-cancer effect by triggering cell cycle arrest and apoptosis in gastric cancer.
Dong J; Zheng N; Wang X; Tang C; Yan P; Zhou HB; Huang J
Eur J Pharmacol; 2018 Jun; 828():67-79. PubMed ID: 29563065
[TBL] [Abstract][Full Text] [Related]
11. Unusual zinc-binding mode of HDAC6-selective hydroxamate inhibitors.
Porter NJ; Mahendran A; Breslow R; Christianson DW
Proc Natl Acad Sci U S A; 2017 Dec; 114(51):13459-13464. PubMed ID: 29203661
[TBL] [Abstract][Full Text] [Related]
12. Hyperthermia induced disruption of mechanical balance leads to G1 arrest and senescence in cells.
Mundhara N; Majumder A; Panda D
Biochem J; 2021 Jan; 478(1):179-196. PubMed ID: 33346336
[TBL] [Abstract][Full Text] [Related]
13. Targeted inhibition of histone deacetylase 6 in inflammatory diseases.
Ran J; Zhou J
Thorac Cancer; 2019 Mar; 10(3):405-412. PubMed ID: 30666796
[TBL] [Abstract][Full Text] [Related]
14. Analysis of Expression and Functions of Histone Deacetylase 6 (HDAC6).
Li M; Zhuang Y; Shan B
Methods Mol Biol; 2016; 1436():85-94. PubMed ID: 27246209
[TBL] [Abstract][Full Text] [Related]
15. Declined Expression of Histone Deacetylase 6 Contributes to Periodontal Ligament Stem Cell Aging.
Li Q; Ma Y; Zhu Y; Zhang T; Zhou Y
J Periodontol; 2017 Jan; 88(1):e12-e23. PubMed ID: 27562218
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte chemotaxis is regulated by histone deacetylase 6, independently of its deacetylase activity.
Cabrero JR; Serrador JM; Barreiro O; Mittelbrunn M; Naranjo-Suárez S; Martín-Cófreces N; Vicente-Manzanares M; Mazitschek R; Bradner JE; Avila J; Valenzuela-Fernández A; Sánchez-Madrid F
Mol Biol Cell; 2006 Aug; 17(8):3435-45. PubMed ID: 16738306
[TBL] [Abstract][Full Text] [Related]
17. HDAC6 α-tubulin deacetylase: a potential therapeutic target in neurodegenerative diseases.
Li G; Jiang H; Chang M; Xie H; Hu L
J Neurol Sci; 2011 May; 304(1-2):1-8. PubMed ID: 21377170
[TBL] [Abstract][Full Text] [Related]
18. Poncirin Induces Apoptosis in AGS Human Gastric Cancer Cells through Extrinsic Apoptotic Pathway by up-Regulation of Fas Ligand.
Saralamma VV; Nagappan A; Hong GE; Lee HJ; Yumnam S; Raha S; Heo JD; Lee SJ; Lee WS; Kim EH; Kim GS
Int J Mol Sci; 2015 Sep; 16(9):22676-91. PubMed ID: 26393583
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of HDAC6 induces pro-inflammatory responses by regulating ROS-MAPK-NF-κB/AP-1 signaling pathways in macrophages.
Youn GS; Lee KW; Choi SY; Park J
Free Radic Biol Med; 2016 Aug; 97():14-23. PubMed ID: 27208785
[TBL] [Abstract][Full Text] [Related]
20. Chelidonine induces mitotic slippage and apoptotic-like death in SGC-7901 human gastric carcinoma cells.
Qu Z; Zou X; Zhang X; Sheng J; Wang Y; Wang J; Wang C; Ji Y
Mol Med Rep; 2016 Feb; 13(2):1336-44. PubMed ID: 26677104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
